WAVE Life Sciences Ltd.
WVE
$13.02
-$0.33-2.47%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -281.79% | 12.83% | -53.29% | -48.55% | 279.95% |
| Total Depreciation and Amortization | 4.92% | 3.34% | 1.10% | -0.60% | -1.19% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 126.63% | 83.29% | 77.79% | 71.92% | 37.93% |
| Change in Net Operating Assets | 112.50% | -94.97% | -1,848.02% | -235.80% | -263.90% |
| Cash from Operations | 22.62% | 3.90% | -67.51% | -88.56% | -31.32% |
| Capital Expenditure | 101.16% | 35.25% | -488.46% | 60.43% | 75.84% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 101.16% | 35.25% | -488.46% | 60.43% | 75.84% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1,022.00% | -82.76% | 1,690.66% | -71.36% | -62.75% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 195,675.00% | -- | -- | -- | -- |
| Cash from Financing | 1,156.95% | -83.95% | 1,690.66% | -71.36% | -62.77% |
| Foreign Exchange rate Adjustments | 41.75% | -124.17% | 153.09% | 178.38% | -277.59% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4,682.88% | -107.80% | -28.33% | -203.87% | -114.66% |